Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole dose-escalation study for secondary stroke prevention
NL-OMON24084Not yet recruiting
- Sponsor
- Albert Schweitzer Hospital
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dipyridamole and aspirin in ischemic stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Albert Schweitzer Hospital. Primary endpoint: Headache frequency. Planned start Sep 2011; status: not yet recruiting.
02
Drugs
dipyridamoleaspirin
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on NL-OMON24084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24084.